Lantheus Holdings, Inc. ( LNTH) - Key Metrics
LNTH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $6.20 | $0.82 | $1.38 | $1.24 |
| 2025Q3 | $5.71 | $0.41 | $1.57 | $1.41 |
| 2025Q2 | $5.52 | $1.15 | $1.27 | $1.08 |
| 2025Q1 | $5.43 | $1.06 | $1.57 | $1.44 |
LNTH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 20.17 |
| 2025Q3 | ? | 31.04 |
| 2025Q2 | ? | 17.80 |
| 2025Q1 | ? | 22.97 |
LNTH Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 2.48% | ? |
| 2025Q4 | 1.86% | ? |
| 2025Q3 | 2.75% | ? |
| 2025Q2 | 1.31% | ? |
| 2025Q1 | 1.47% | ? |
LNTH
Price: $100.98
52 week price:
Payout Ratio Range:
Earnings Per Share: 4.19 USD
P/E Ratio: 22.45
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 24390
Ebitda: 17.5 millionMarket Capitalization: 6.1 billion